loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_1995_015___rev_02 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Zambon Group SpA

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Zambon Group SpA Lonigo IT (1)

    filter

    01 Naproxen (1)

    filter

    01 Italy (1)

    filter

    01 Expired (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    Zambon Group SpA Lonigo IT

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Naproxen

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 1995-015 - Rev 02
    Expired
    Chemical
    2004-12-20
    2005-12-07
    731
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 1995-015 - Rev 02 of Zambon Group Spa Lonigo It

    Looking for Certificates of Suitability (CEPs) for R1-CEP 1995-015 - Rev 02 of Zambon Group Spa Lonigo It 1

    20

    Zambon Group Spa Lonigo It, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    They are recognized for Committed to providing Highly Customized Solutions for all your Development Programs.

    One of their significant offerings is Naproxen, supported by a 'Expired' Certificate of Suitability (CEP) with the number R1-CEP 1995-015 - Rev 02

    This Chemical Type CEP, issued on December 20, 2004, remains in force until December 07, 2005, ensuring its reliability within the pharmaceutical industry.

    Substance Number 731 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY